Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
  • Hegar@fedia.io
    87·
    14 hours ago

    “The mindset right now is that the GLP-1 hormone itself is the secret sauce to weight loss,” DiMarchi said. "What we’ve found in rodents and monkeys is that the combination of glucagon and GIP activity alone are sufficient to achieve comparable weight loss, without the lengthy dosage adjustment and adverse GI side effects

    This article is saying that slightly different products can also produce weight loss.